Chen N, Luo T, Raymond LA. 1999. Subtype-dependence of NMDA
receptor channel open probability. J Neurosci 19:6844–6854.
Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA,
Scherzinger E, Wanker EE, Mangiarini L, Bates GP. 1997. Formation
of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90:537–548.
Davies SW, Turmaine M, Cozens BA, Raza AS, Mahal A, Mangiarini L,
Bates GP. 1999. From neuronal inclusions to neurodegeneration: neuropathological investigation of a transgenic mouse model of Huntington's disease. Philos Trans R Soc Lond B Biol Sci 354:981–989.
DiFiglia M. 1990. Excitotoxic injury of the neostriatum: a model for
Huntington's disease. Trends Neurosci 13:286–289.
Dugan LL, Sensi SL, Canzoniero LM, Handran SD, Rothman SM, Lin
TS, Goldberg MP, Choi DW. 1995. Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N- methyl-D-aspartate. J Neurosci 15:63777–63788.
Ferrante RJ, Kowall NW, Beal MF, Richardson EP Jr, Bird ED, Martin
JB. 1985. Selective sparing of a class of striatal neurons in Huntington's
disease. Science 230:561–563.
Flores-Hernandez J, Cepeda C, Hernandez-Echeagaray E, Calvert CR,
Jokel ES, Fienberg AA, Greengard P, Levine MS. 2002. Dopamine
enhancement of NMDA currents in dissociated medium-sized striatal
neurons: role of D1 receptors and DARPP-32. J Neurophysiol
88:3010–3020.
Hollmann M, Heinemann S. 1994. Cloned glutamate receptors. Annu
Rev Neurosci 17:31–108.
Huntington's Disease Collaborative Research Group. 1993. A novel gene
containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971–983.
Ishii T, Moriyoshi K, Sugihara H, Sakurada K, Kadotani H, Yokoi M,
Akazawa C, Shigemoto R, Mizuno N, Masu M, Nakanishi S. 1993.
Molecular characterization of the family of the N-methyl-D-aspartate
receptor subunits. J Biol Chem 268:2836–2843.
Kirson ED, Schirra C, Konnerth A, Yaari Y. 1999. Early postnatal switch
in magnesium sensitivity of NMDA receptors in rat CA1 pyramidal
cells. J Physiol 521:99–111.
Klapstein GJ, Fisher RS, Zanjani H, Cepeda C, Jokel ES, Chesselet MF,
Levine MS. 2001. Electrophysiological and morphological changes in
striatal spiny neurons in R6/2 Huntington's disease transgenic mice.
J Neurophysiol 86:2667–2677.
Kuppenbender KD, Standaert DG, Feuerstein TJ, Penney JB Jr, Young
AB, Landwehrmeyer GB. 2000. Expression of NMDA receptor subunit
mRNAs in neurochemically identified projection and interneurons in
the human striatum. J Comp Neurol 419:407–421.
Laforet GA, Sapp E, Chase K, McIntyre C, Boyce FM, Campbell M,
Cadigan BA, Warzecki L, Tagle DA, Reddy PH, Cepeda C, Calvert
CR, Jokel ES, Klapstein GJ, Ariano MA, Levine MS, DiFiglia M, Aronin N. 2001. Changes in cortical and striatal neurons predict behavioral
and electrophysiological abnormalities in a transgenic murine model of
Huntington's disease. J Neurosci 21:9112–9123.
Levine MS, Klapstein GJ, Koppel A, Gruen E, Cepeda C, Vargas ME,
Jokel ES, Carpenter EM, Zanjani H, Hurst RS, Efstratiadis A, Zeitlin
S, Chesselet MF. 1999. Enhanced sensitivity to N-methyl-D-aspartate
receptor activation in transgenic and knockin mouse models of Huntington's disease. J Neurosci Res 58:515–532.
Lione LA, Carter RJ, Hunt MJ, Bates GP, Morton AJ, Dunnett SB.
1999. Selective discrimination learning impairments in mice expressing
the human Huntington's disease mutation. J Neurosci 19:10428–10437.
Luthi-Carter R, Strand A, Peters NL, Solano SM, Hollingsworth ZR,
Menon AS, Frey AS, Spektor BS, Penney EB, Schilling G, Ross CA,
Borchelt DR, Tapscott SJ, Young AB, Cha JH, Olson JM. 2000.
Decreased expression of striatal signaling genes in a mouse model of
Huntington's disease. Hum Mol Genet 9:1259–1271.
